Carley Brian T 4

What Happened

• Brian T. Carley, a director of Medpace Holdings, exercised stock options on Feb 13, 2026 to acquire 6,472 shares at an exercise price of $54.99 per share, for a total exercise cost of $355,895. The Form 4 also reports a simultaneous disposition of 6,472 shares at $0.00 (zero proceeds) under the same transaction code (M = option exercise/conversion).

Key Details

• Transaction date: 2026-02-13; Filing date (Form 4): 2026-02-17.
• Exercise price: $54.99 per share; reported acquisition value: $355,895.
• Disposition reported: 6,472 shares at $0.00 (zero proceeds) — reported as part of the derivative conversion.
• Footnote: The option vested in full on May 14, 2020.
• Shares owned after the transaction: Not stated in the provided filing.
• No late-filing flag noted in the provided record.

Context

• The "M" transaction code indicates an option exercise/conversion. The paired acquisition and zero‑proceeds disposition often reflects shares surrendered to the company (or withheld) to cover the exercise cost or tax withholding in a cashless or stock‑surrender arrangement; the filing does not specify which method was used.
• This is a routine insider exercise event; exercises do not by themselves signal a directional view of the stock unless shares are retained or sold into the market.